Literature DB >> 15014689

Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care Physicians.

Raphael J. Leo1, Rajesh Narendran.   

Abstract

Primary care physicians may be directly or indirectly involved in the management of the bipolar patient. Bipolar affective illness is a chronic, recurrent disorder. Patients, their families and support systems, and the general public can face profound and enduring consequences if the illness is untreated or poorly treated. Consequently, increasing attention has been directed at developing treatment strategies to control symptoms associated with bipolar disorder. While lithium has been the mainstay of treatment for many years, recent investigations have demonstrated the utility of a number of anticonvulsant medications in bipolar disorder. This review will discuss the literature on anticonvulsant efficacy in bipolar disorder in light of the treatment guidelines set forth by the Bipolar Treatment Expert Consensus Panel and the American Psychiatric Association. To orient the clinician, issues related to anticonvulsant use, dosing, adverse effects, and drug interactions are also discussed.

Entities:  

Year:  1999        PMID: 15014689      PMCID: PMC181066          DOI: 10.4088/pcc.v01n0304

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  109 in total

1.  Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder.

Authors:  J R Calabrese; G A Delucchi
Journal:  Am J Psychiatry       Date:  1990-04       Impact factor: 18.112

2.  Major and minor birth malformations and antiepileptic drugs.

Authors:  S Koch; G Lösche; E Jager-Romän; S Jakob; D Rating; A Deichl; H Helge
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

3.  Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.

Authors:  D Lindhout; J G Omtzigt; M C Cornel
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

4.  Gabapentin in the treatment of bipolar disorder.

Authors:  C B Schaffer; L C Schaffer
Journal:  Am J Psychiatry       Date:  1997-02       Impact factor: 18.112

5.  Valproic acid hepatic fatalities: a retrospective review.

Authors:  F E Dreifuss; N Santilli; D H Langer; K P Sweeney; K A Moline; K B Menander
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

6.  Outcome of bipolar disorder on long-term treatment with lithium.

Authors:  R A O'Connell; J A Mayo; L Flatow; B Cuthbertson; B E O'Brien
Journal:  Br J Psychiatry       Date:  1991-07       Impact factor: 9.319

7.  Treatment of valproate tremors.

Authors:  B J Karas; B J Wilder; E J Hammond; A W Bauman
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

Review 8.  Valproate in psychiatric disorders: literature review and clinical guidelines.

Authors:  S L McElroy; P E Keck; H G Pope; J I Hudson
Journal:  J Clin Psychiatry       Date:  1989-03       Impact factor: 4.384

9.  Carbamazepine in the prophylaxis of mood disorders.

Authors:  C Stuppaeck; C Barnas; C Miller; J Schwitzer; W W Fleischhacker
Journal:  J Clin Psychopharmacol       Date:  1990-02       Impact factor: 3.153

10.  Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial.

Authors:  J Messenheimer; R E Ramsay; L J Willmore; R F Leroy; J J Zielinski; R Mattson; J M Pellock; A M Valakas; G Womble; M Risner
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

View more
  8 in total

1.  A systematic review of population pharmacokinetics of valproic acid.

Authors:  Janthima Methaneethorn
Journal:  Br J Clin Pharmacol       Date:  2018-02-28       Impact factor: 4.335

2.  Psychotropic drugs and their impact on the treatment of paediatric dental patients.

Authors:  E Hajishengallis
Journal:  Eur Arch Paediatr Dent       Date:  2013-06-21

3.  External evaluation of a published population pharmacokinetic model of valproic acid in Thai manic patients.

Authors:  Janthima Methaneethorn; Manupat Lohitnavy
Journal:  Eur J Hosp Pharm       Date:  2018-09-26

Review 4.  Valproate for acute mania.

Authors:  Janina Jochim; Raphael P Rifkin-Zybutz; John Geddes; Andrea Cipriani
Journal:  Cochrane Database Syst Rev       Date:  2019-10-07

Review 5.  Signature-based approaches for informed drug repurposing: targeting CNS disorders.

Authors:  Rammohan Shukla; Nicholas D Henkel; Khaled Alganem; Abdul-Rizaq Hamoud; James Reigle; Rawan S Alnafisah; Hunter M Eby; Ali S Imami; Justin F Creeden; Scott A Miruzzi; Jaroslaw Meller; Robert E Mccullumsmith
Journal:  Neuropsychopharmacology       Date:  2020-06-30       Impact factor: 8.294

6.  Comparative pharmacokinetics of valproic acid among Pakistani and South Korean patients: A population pharmacokinetic study.

Authors:  Muhammad Usman; Qurrat-Ul-Ain Shaukat; Muhammad Imran Khokhar; Rabiea Bilal; Rizwan Rasul Khan; Hafiz Asad Saeed; Mohsin Ali; Humaira Majeed Khan
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

7.  Outpatient Treatment of Tic Disorders Among Children and Adults.

Authors:  Joseph L Smith; Sean Gregory; Nicole McBride; Tanya K Murphy; Eric A Storch
Journal:  Mov Disord Clin Pract       Date:  2017-03-11

Review 8.  Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes.

Authors:  Catherine E Creeley; Lisa K Denton
Journal:  Brain Sci       Date:  2019-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.